Supplements
bromelain prevents cancer
In plain terms: Does bromelain fight cancer?
Part of: 🧪 bromelain
Lab-only. It slows cancer cells in a dish and in some animal studies, but there's no human evidence it prevents or treats cancer.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Lab-only. Bromelain shows antiproliferative and pro-apoptotic activity against cancer cells in vitro and in some animal models, but there is no human evidence it prevents or treats cancer.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sanlier N, Irmak E, Ankarali E 2026 · Frontiers in nutrition | animal | mixed | low | Narrative review of bromelain's therapeutic potential across multiple disease areas including cancer; notes 'emerging evidence' for cancer but explicitly states most findings are from in vitro/animal studies with limited clinical evidence. |
| Balakrishnan SB, Ibrahim L, Shanmugasundaram E, Saleh N, Thambusamy S 2025 · ACS omega | in-vitro | supports | low | Bromelain encapsulated in PVA/hydroxyethyl cellulose nanofiber scaffolds inhibited growth of HeLa (cervical cancer) cells in vitro via sustained release. |
| Pavan R, Jain S, Shraddha, Kumar A 2012 · Biotechnol Res Int | animal | supports | low | Narrative review, no new data: 'This paper reviews the important properties and therapeutic applications of bromelain'. The anticancer section re-describes preclinical work: 'Most of the in vitro and in vivo studies on anticancer activity of bromelain are concentrated on mouse and human cells ... treated with bromelain preparations.' Zero weight. |
| Altpeter S, Wach MM, Giran E, Derby J, Beasley S, Pingpank JF, Ongchin M, Choudry HA 2026 · Annals of surgical oncology | observational | mixed | low | Human expanded-access program: intra-tumoral BromAc (bromelain+acetylcysteine) in 10 patients with unresectable pseudomyxoma peritonei reduced mucinous tumor volume (median 48.6%) in most tumors over repeated treatments; some symptom improv |
| Kumar V, Mangla B, Javed S, Ahsan W, Kumar P, Garg V, Dureja H 2023 · Food Funct | observational | mixed | low | Review: bromelain shows in-vitro/animal antiproliferative and pro-apoptotic activity; no human cancer evidence. |
| Wajih N, Erali RA, Forsythe SD, Schaaf CR, Shen P, Levine EA, Soker S, Morris DL, Votanopoulos KI 2024 · Annals of surgical oncology | in-vitro | supports | moderate | In patient-derived tumor organoids and an appendiceal cancer cell line, bromelain reduced organoid viability >66% at 48h, decreased proliferation markers, increased apoptosis (caspase 3/7), and potentiated cytotoxicity of HIPEC chemotherapy |
| Jai J, Liu Y, Han X, Vong K 2026 · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | in-vitro | supports | moderate | Bromelain (and papain) delivered via engineered chagasin protein carriers showed antiproliferative effects against targeted cancer cell lines in vitro, demonstrating proof-of-concept for cancer-specific protease release. |
| d10-66235-kumj-1854809 2026 · Kastamonu Medical Journal | in-vitro | mixed | low | In A549 lung cancer cells, bromelain alone decreased GSDMD (pyroptosis marker) expression and reduced GSDME/Bcl-2, while combination with Sambucus nigra showed different, sometimes opposing, effects on pyroptosis/apoptosis genes and miRNA e |
| Zhang S, Wang DY, Li J, Wu X, Huo Q, Song S, Tian XH, Ma F, Shen J, Shi L 2025 · Biomaterials science | animal | supports | moderate | In mice, self-targeting liposomes co-loaded with bromelain (to degrade tumor extracellular matrix), antibiotic, and gemcitabine improved chemotherapeutic efficacy against infected pancreatic cancer tumors versus bromelain/gemcitabine alone. |
| Shamsuri AS, Sim EU 2024 · BMC research notes | mechanism | supports | low | In silico molecular docking predicted bromelain binds key oncogenic proteins (PIK3CA, EGFR, mTOR, beta-catenin, BCL2) in nasopharyngeal cancer, suggesting a hypothetical PI3K/Akt-modulating anti-tumor mechanism. |
| Olivera-Salazar R, Villarejo Campos P, Barrueco Gutiérrez R, Vega-Clemente L, Serrano LJ, García Gómez-Heras S, García-Olmo D, García-Arranz M 2025 · International journal of molecular sciences | in-vitro | supports | low | Human colorectal cancer cell lines treated with sodium butyrate + bromelain combination showed enhanced inhibition of proliferation and induction of apoptosis in vitro versus either agent alone. |
| Kumar D, Suchitra, Mundlia J, Yadav SK, Yadav D, Aggarwal N, Chopra H, Kumar V, Kamal MA 2025 · Current pharmaceutical design | observational | mixed | moderate | Narrative review of pineapple/bromelain's chemotherapeutic potential concluding most evidence comes from in vitro and animal cancer models, with promising but unvalidated preliminary results not yet translated to clinical settings. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.